Table 1.
Cytotoxic-induced effects on HepG2 and CRL-4020 cells by various concentrations of bionanomaterial at various incubation times
HSA–MWCNTs concentration | Cytotoxicity effects at different incubation intervals (%) |
|||||
---|---|---|---|---|---|---|
1 min | 30 min | 1 h | 3 h | 5 h | 24 h | |
CRL-4020 control | 0 | 0.2 | 0.3 | 0.4 | 0.9 | 1.6 |
HepG2 control | 0 | 0.1 | 0.3 | 0.5 | 1.1 | 1.3 |
CRL-4020 1 mg/L | 0.3 | 0.5 | 0.7 | 1.9 | 2.4 | 3.8 |
HepG2 1 mg/L | 0.5 | 0.8 | 0.9 | 2.2 | 2.5 | 3.6 |
CRL-4020 5 mg/L | 0.6 | 0.9 | 1 | 2.4 | 3.1 | 4.2 |
HepG2 5 mg/L | 0.4 | 0.7 | 0.8 | 2.6 | 3.2 | 4.4 |
CRL-4020 20 mg/L | 0.7 | 0.8 | 1.2 | 3 | 3.1 | 4.8 |
HepG2 20 mg/L | 0.8 | 1.2 | 1.2 | 2.6 | 2.8 | 4.5 |
CRL-402050 mg/L | 0.6 | 0.8 | 1.8 | 2.2 | 2.8 | 4.9 |
HepG2 50 mg/L | 1.4 | 1.5 | 1.6 | 2.2 | 2.8 | 6.2 |
Abbreviations: HSA, human serum albumin; MWCNTs, multiwalled carbon nanotubes.